The News Feed
News
LAMP Study: Atropine 0.05% Effective For Myopia Control at Five Years
The intervention even performed equally well in patients who had to restart treatment after a year of recession.
March 18, 2024
Study Links PDR Prevalence to Quality of Medical Insurance
Individuals with worse (or no) coverage had higher rates, highlighting the need for better screening methods in vulnerable populations.
March 18, 2024
Endogenous Endophthalmitis Rates Higher in the South
While regional variation exists in the infectious microbes that cause the condition, methicillin-sensitive Staphylococcus aureus was the most common.
March 18, 2024
Kids with Convergence Excess Least Amenable to DIMS Lens Therapy for Myopia
This was found when compared with other types of vergence dysfunction in a population of Chinese children.
March 15, 2024
Popular Drug for Type 2 Diabetes May Reduce Glaucoma Risk
In a nationwide study, GLP-1RA treatment decreased the risk of development by 19%.
March 15, 2024
Cardiovascular Disease May Elevate Risk for POAG
Study shows cardiac surgery patients have lower vascular and structural parameters in the optic nerve hypoplasia and macula compared to open-angle glaucoma patients.
March 15, 2024
Survey: For Relief, DED Patients Most Likely to Rest Eyes, Drink Water, Use Compresses
Study investigates public enthusiasm for these and other behavioral modifications that might mitigate DED.
March 14, 2024
OCT Study Finds Outer Retinal Hallmarks of Intermediate AMD
Splitting of the RPE/basal lamina/Bruch’s membrane region, reticular pseudodrusen and subretinal drusen deposits are were prognostic.
March 14, 2024
Study Supports Bevacizumab as First-line DME Therapy
This affordable anti-VEGF conferred real-world visual gains and cost savings with fewer injections over time.
March 14, 2024
Goldmann Stimulus Size II Best for 10-2 VF Diagnostic Test
This as well as the III option provided a better discrimination ability between patients with chiasm compression and healthy controls than size I.
March 13, 2024
LOAD MORE
Current News
Most Popular
LAMP Study: Atropine 0.05% Effective For Myopia Control at Five Years
March 18, 2024
Study Links PDR Prevalence to Quality of Medical Insurance
March 18, 2024
Endogenous Endophthalmitis Rates Higher in the South
March 18, 2024
Kids with Convergence Excess Least Amenable to DIMS Lens Therapy for Myopia
March 15, 2024
Popular Drug for Type 2 Diabetes May Reduce Glaucoma Risk
March 15, 2024
×
Full Image